Connect with us

Life Sciences

Priority and IQ BackOffice Announce Strategic Technology Partnership

CPX integration enhances IQ BackOffice’s accounts payable payment capabilities Priority Technology Holdings, (Priority), the platform for unified commerce…

Published

on

This article was originally published by AITHORITY
Priority and IQ BackOffice Announce Strategic Technology Partnership

CPX integration enhances IQ BackOffice’s accounts payable payment capabilities

Priority Technology Holdings, (Priority), the platform for unified commerce that delivers integrated payments and banking at scale, has announced a strategic partnership with IQ BackOffice, a global leader in financial process automation and business process outsourcing.

“Top public and private equity-backed companies choose IQ BackOffice to implement and manage world-class financial processes because IQ knows how to fully take advantage of automation to deliver to our clients greater efficiency, improved visibility and controls, and lower costs”

IQ BackOffice provides best-practice business processes and automation for Accounts Payable (AP) through their proprietary cloud-based software product, Streamlinea. This solution leverages the client’s existing infrastructure with state-of-the-art automation to increase efficiency and quality with real-time information and up to 70% cost reduction.

Recommended AI News: Mobileum and Digis Squared Announce Partnership to Provide Comprehensive Edge-to-Edge Network Testing and Analytics

Under the integration, Priority’s accounts payable solution CPX will provide IQ BackOffice’s customers with a streamlined accounting process enabled by technology and designed to fully automate, integrate and monetize accounts payable payments. The integration supports payments through any disbursement partner using any payment modality including check, ACH and virtual card.

“Top public and private equity-backed companies choose IQ BackOffice to implement and manage world-class financial processes because IQ knows how to fully take advantage of automation to deliver to our clients greater efficiency, improved visibility and controls, and lower costs,” said David Schnitt, President & CEO, IQ BackOffice. “By integrating CPX into our platform we will be able to further accelerate client’s digital transformation and positive ROI while minimizing their risks.”

Recommended AI News: Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts

“By integrating our industry-leading technology with IQ BackOffice’s accounting process solutions, we are making it easier for companies of all sizes to manage their accounts payable processes more efficiently while generating bottom-line revenue,” said Stephen Tackett, Executive Vice President and head of the B2B division for Priority. “Payment success is not just about having a software technology; it’s also about having access to the right experts who can help you implement your new system quickly and easily. Our partnership offers both of these things to IQ BackOffice’s customers.”

Recommended AI News: Kount, an Equifax Company, Expands International Presence

[To share your insights with us, please write to sghosh@martechseries.com]

The post Priority and IQ BackOffice Announce Strategic Technology Partnership appeared first on AiThority.

therapeutics
private equity

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending